Laboratory Corporation of America Holdings (LH)

Healthcare · Diagnostics & Research · S&P 500
$311.71 +0.99% on the day Market cap $25.9B 52-week range $244.52 to $341.80 Prices as of Oct 7, 2026

What the price implies

A reverse DCF: instead of guessing a fair value, it asks what growth today's price already assumes. How it works.

Free cash flow growth the price needs
6% a year for 10 years

At a market value of $25.9B, Laboratory Corporation of America Holdings's free cash flow of $1.2B (fiscal 2025) would need to grow about 6% a year for the stock to be worth today's price. That is close to what the company has delivered over the last 9 years.

Assumes a 9% discount rate and 3% growth after year 10, on free cash flow (operating cash flow minus capital spending) from Laboratory Corporation of America Holdings's SEC filings. Change any assumption, or model revenue and margins instead, in the Modeling tab, or try your own numbers in the reverse DCF calculator.

Implied by the price5.9% a year
Free cash flow, last 9 years3.1% a year
Revenue, same period4.3% a year
Price to free cash flow21.5x

Fundamental grade

C

Five factors scored 1 to 9 from LH's latest numbers, weighted into one grade. It describes the business, not whether the stock is a buy.

Valuation6
Profitability5
Growth6
Financial health4
Cash efficiency4

Key numbers

P/E (trailing)28.0x
P/E (forward)17.5x
Price / free cash flow21.5x
EV / EBITDA13.2x
Price / sales1.81x
Price / book2.94x
Revenue growth+5.8%
Operating margin10.4%
Net margin7.0%
Return on equity11.7%
Dividend yield0.92%
Debt / equity1.15x

Results from SEC filings

Fiscal years, from Laboratory Corporation of America Holdings's 10-K filings. The deep dive has 15+ years, quarters and every line.

Fiscal year20212022202320242025
Revenue$13.1B$11.9B$12.2B$13.0B$14.0B
Net income$2.4B$1.3B$418M$746M$876M
Free cash flow$2.7B$1.5B$874M$1.1B$1.2B
EPS (diluted)$24.39$13.97$4.77$8.84$10.46
Operating margin23.2%12.1%6.0%8.4%9.9%

Where the revenue comes from

Revenue by segments, fiscal 2025.

Diagnostics$10.9B78%
Biopharma Laboratory Services$3.1B22%

Superinvestors who own LH

From each investor's latest 13F filing (what a 13F shows). 7 of the investors we track hold it.

InvestorLast quarterValue% of portfolioQuarter
Ric Dillon
Diamond Hill Capital Management
Trimmed $168M1.3%Q2 2026
John Rogers
Ariel Investments
Trimmed $98M0.98%Q2 2026
Charles Brandes
Brandes Investment Partners, LP
Added $70M0.49%Q2 2026
Wallace Weitz
Weitz Investment Management
Held $28M1.9%Q2 2026
Joel Greenblatt
Gotham Asset Management
Trimmed $25M0.06%Q2 2026
Cliff Asness
AQR Capital Management
Added $17M0.01%Q2 2026
Mark Boyar
Boyar Asset Management
Added $1M0.62%Q2 2026

Insider buying

Open-market purchases by Laboratory Corporation of America Holdings's executives and directors in the last 12 months, from SEC Form 4 filings. What insider buying tells you.

DateInsiderSharesPriceValue
Feb 11, 2026 April Mcclain Delaney
0$289.95—
Feb 11, 2026 April Mcclain Delaney
0$289.95—
Feb 11, 2026 April Mcclain Delaney
0$289.95—
Feb 4, 2026 April Mcclain Delaney
0$276.19—
Feb 4, 2026 April Mcclain Delaney
0$276.19—
Feb 4, 2026 April Mcclain Delaney
0$276.19—
Jan 28, 2026 April Mcclain Delaney
0$268.07—
Jan 28, 2026 April Mcclain Delaney
0$268.07—
Jan 28, 2026 April Mcclain Delaney
0$268.07—
Nov 17, 2025 April Mcclain Delaney
0$261.35—

Get an alert at your buy price

Pick the price you'd be interested at. We'll email you when LH trades at or below it.

$

Free accounts get 3 price alerts. No card needed.

In the full deep dive

DCF fair value per share
Yearly return (IRR) at today's price
Growth implied by revenue and margins
15+ years of statements and quarters

Questions

What growth does Laboratory Corporation of America Holdings's stock price imply?

At a market value of $25.9B, Laboratory Corporation of America Holdings would need its free cash flow to grow about 6% a year for 10 years (discounted at 9%, 3% growth after that) to be worth today's price. Over the last 9 years its free cash flow grew 3% a year.

Are Laboratory Corporation of America Holdings insiders buying the stock?

10 open-market insider purchases of LH in the last 12 months, from SEC Form 4 filings.

Which superinvestors own Laboratory Corporation of America Holdings?

7 of the superinvestors Investingly tracks hold LH in their latest 13F, including Ric Dillon, John Rogers, Charles Brandes.

Prices and ratios as of Oct 7, 2026; statements from SEC filings. Information only, not investment advice. Superinvestor holdings come from 13F filings, which are filed up to 45 days after each quarter ends.